We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 0.34% | 1,339.50 | 1,339.00 | 1,339.50 | 1,340.50 | 1,333.00 | 1,335.00 | 837,715 | 12:23:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.26 | 55.34B |
Date | Subject | Author | Discuss |
---|---|---|---|
14/3/2023 07:41 | I got back in yesterday at 1385 and have a top up order in at 1370. Hopefully this rns sees us push into the 14's today but you never can tell with GSK and especially in this market!! Good luck all 👍🏻 | tuftymatt | |
14/3/2023 07:29 | The RNS does look good. Does anyone have a economic value of the drug's potential worth? | netcurtains | |
13/3/2023 18:56 | I would imagine Pfizer will need to raise cash - sell stake in Haleon?? | tradermichael | |
13/3/2023 18:33 | It probably knocks out Pfizer for any corporate action to take GSK. That leaves Novartis once they IPO Sandoz. | alphorn | |
13/3/2023 18:28 | I doubt they could afford it as no-one would lend them the money! | rikky72 | |
13/3/2023 15:27 | Yet Pfizer is UP 2.5%. One wonders what it would have done to the GSK price if they'd made the bid .... ;0) | tradermichael | |
13/3/2023 15:20 | That is massive .... | tradermichael | |
13/3/2023 14:46 | A large deal - Pfizer has agreed to acquire antibody-drug conjugate (ADC) developer Seagen for $43 billion. The potential acquisition of Seagen (previously Seattle Genetics) has been circulating news outlets since June last year when the Wall Street Journal report | alphorn | |
13/3/2023 09:57 | Another one I never get is Admiral Insurance Google says the dividend yield is 4.48% Wall street journal say yield is 8.62% Advfn says the yield is 8.62% Is google right or is WSJ? Its difficult for ordinary investors to see... Any ideas? PS - GOOGLE is right. | netcurtains | |
13/3/2023 09:13 | I think the discrepancies arise from the fact that you cannot compare historic p/e with prospective p/e, because there was such a massive split when Healthcare was divested. The amounts presented by the company are for Continuing operations and Adjusted results excludes the Consumer Healthcare business discontinued operation. The amounts presented in the results for discontinued EPS are for the demerger of the Consumer Healthcare business | tradermichael | |
13/3/2023 08:59 | 😃 No one is helping. I get that. Each to their own. | netcurtains | |
13/3/2023 08:39 | As investors are primarily interested a company's future profits, it is common to calculate the PE based on forecast earnings. The PE calculated using the previous financial year's earnings is called the historical PE. | tradermichael | |
13/3/2023 08:32 | The PE (price earnings) ratio is the share price divided by the earnings per share so you have the information to hand after all! | patientcapital | |
13/3/2023 08:10 | PC: Sure - I've got that. 😃 What I haven't got is what the figure is. | netcurtains | |
13/3/2023 08:07 | Net if you reread the finals you'll understand the PE discrepancy. | patientcapital | |
13/3/2023 08:04 | GARYCOOK thanks. Weird as WSJ that had the correct dividend yield of 4.13 WSJ say they calculated 3.5% on Friday so could be right | netcurtains | |
13/3/2023 07:49 | thanks Gary. Do you know what the PE ratio is? Wall Street Journal has it at 3.5 Google has it at 12 Which one is nearer? | netcurtains | |
13/3/2023 01:37 | GSK Current Yield Details - 4.13% Dividends Declared in Previous 12 months Year End Type Announce Date Ex-Dividend Date Payment Date Dividend 12/2022 Q1 27-Apr-22 19-May-22 01-Jul-22 14p 12/2022 Q2 27-Jul-22 18-Aug-22 06-Oct-22 16.25p 12/2022 Q3 02-Nov-22 17-Nov-22 12-Jan-23 13.75p 12/2022 Q4 01-Feb-23 23-Feb-23 13-Apr-23 13.75p Total: 57.75p Dividend Yield = Total Dividends Current Share Price = 57.75p 1398.60p = 4.13% Dividend Cut - 2022 annual dividend cut from 80p to 57.75p. GSK expects to pay an annual dividend of 56.5p for 2023. | garycook | |
12/3/2023 19:29 | WSJ says GSK has the lowest PE ratio in FTSE 100 3.95 PE Google says its about 12 Advfn about 16. Either way the Dividend Yield is about 6.5% which isn't bad. But which PE ratio is right? Is it about 3.5? or is it about 12? | netcurtains | |
10/3/2023 12:57 | Porsche, you are the biggest laughing stock of all posters. You must be one poor man (and not only financially). | supermarky | |
10/3/2023 10:54 | …and back under 14…..what a dog this is. | porsche1945 | |
10/3/2023 10:46 | Hopefully get the RSV contract in may , good news in July with court case and share price should recover | alibizzle | |
10/3/2023 10:45 | Zantac fears are looming. | abdullla |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions